Nasdaq:US$15.10 (-0.04) | HKEX:HK$24.12 (+0.32) | AIM:£2.22 (+0.02)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2014-06-03

ASCO 2014: A phase 1b study of VEGFR inhibitor fruquintinib in patients with pretreated advanced colorectal cancer